| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A cut above the rest?
|
McMichael, Jonathan W
|
|
2002
|
8 |
4 |
p. 157-158
2 p.
|
artikel
|
| 2 |
An aPPARently protective mechanism for keratinocytes in wounded skin
|
Grose, Richard
|
|
2002
|
8 |
4 |
p. 149-151
3 p.
|
artikel
|
| 3 |
APP on the move
|
Müller, Ulrike
|
|
2002
|
8 |
4 |
p. 152-155
4 p.
|
artikel
|
| 4 |
Aromatase inhibitors continue their ATAC on tamoxifen
|
Nicholls, Henry
|
|
2002
|
8 |
4 |
p. S12-S13
2 p.
|
artikel
|
| 5 |
Carbohydrate-binding proteins in cancer, and their ligands as therapeutic agents
|
Nangia-Makker, Pratima
|
|
2002
|
8 |
4 |
p. 187-192
6 p.
|
artikel
|
| 6 |
Caretaker tumour suppressor genes that defend genome integrity
|
Levitt, Nicola C
|
|
2002
|
8 |
4 |
p. 179-186
8 p.
|
artikel
|
| 7 |
Complexities in the development of cyclin-dependent kinase inhibitor drugs
|
Sausville, Edward A.
|
|
2002
|
8 |
4 |
p. S32-S37
6 p.
|
artikel
|
| 8 |
Epigenomics and epigenetic therapy of cancer
|
Brown, Robert
|
|
2002
|
8 |
4 |
p. S43-S48
6 p.
|
artikel
|
| 9 |
Gene expression profiling to predict lymphoma outcome
|
Ramsay, Michele
|
|
2002
|
8 |
4 |
p. 159-
1 p.
|
artikel
|
| 10 |
GNAS1 imprinting: the latest twist
|
Aldred, Micheala
|
|
2002
|
8 |
4 |
p. 159-160
2 p.
|
artikel
|
| 11 |
HIF-1 and tumor progression: pathophysiology and therapeutics
|
Semenza, Gregg L.
|
|
2002
|
8 |
4 |
p. S62-S67
6 p.
|
artikel
|
| 12 |
Histone modification: the ‘next wave’ in cancer therapeutics
|
Chung, Daphne
|
|
2002
|
8 |
4 |
p. S10-S11
2 p.
|
artikel
|
| 13 |
Hsp90 inhibitors as novel cancer chemotherapeutic agents
|
Neckers, Len
|
|
2002
|
8 |
4 |
p. S55-S61
7 p.
|
artikel
|
| 14 |
In brief
|
Weitzman, J
|
|
2002
|
8 |
4 |
p. 160-161
2 p.
|
artikel
|
| 15 |
Interleukin-5 and eosinophils as therapeutic targets for asthma
|
Foster, Paul S
|
|
2002
|
8 |
4 |
p. 162-167
6 p.
|
artikel
|
| 16 |
Molecular basis of cholesterol homeostasis: lessons from Tangier disease and ABCA1
|
Oram, John F
|
|
2002
|
8 |
4 |
p. 168-173
6 p.
|
artikel
|
| 17 |
Proteasome inhibition: a novel approach to cancer therapy
|
Adams, Julian
|
|
2002
|
8 |
4 |
p. S49-S54
6 p.
|
artikel
|
| 18 |
Searching for clues to premature aging
|
Uitto, Jouni
|
|
2002
|
8 |
4 |
p. 155-157
3 p.
|
artikel
|
| 19 |
STI571 (Gleevec™) as a paradigm for cancer therapy
|
Druker, Brian J.
|
|
2002
|
8 |
4 |
p. S14-S18
5 p.
|
artikel
|
| 20 |
The coming of age of 1,25-dihydroxyvitamin D3 analogs as immunomodulatory agents
|
Mathieu, Chantal
|
|
2002
|
8 |
4 |
p. 174-179
6 p.
|
artikel
|
| 21 |
The Dictionary of Gene Technology (2nd edition): A landmark research tool for the post-genomic era
|
Gurwitz, David
|
|
2002
|
8 |
4 |
p. 193-
1 p.
|
artikel
|
| 22 |
The emerging fields of suicide gene therapy and virotherapy
|
Kirn, David
|
|
2002
|
8 |
4 |
p. S68-S73
6 p.
|
artikel
|
| 23 |
The ErbB receptor family: a therapeutic target for cancer
|
de Bono, Johann S.
|
|
2002
|
8 |
4 |
p. S19-S26
8 p.
|
artikel
|
| 24 |
Therapeutic exploitation of the p53 pathway
|
Lane, David P.
|
|
2002
|
8 |
4 |
p. S38-S42
5 p.
|
artikel
|
| 25 |
Translating basic cancer research into new cancer therapeutics
|
Workman, Paul
|
|
2002
|
8 |
4 |
p. S1-S9
9 p.
|
artikel
|
| 26 |
Unraveling the complexities of the Raf/MAP kinase pathway for pharmacological intervention
|
Herrera, Roman
|
|
2002
|
8 |
4 |
p. S27-S31
5 p.
|
artikel
|
Tijdschrift beschrijving